IDEXX LABORATORIES DANMARK ApS: Financial statements 2012
CVR: 26996279
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
IDEXX LABORATORIES DANMARK ApS (CVR 26996279) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 5,050,455 and a net result of DKK 732,019. Equity in the 2012 report amounted to DKK 5,829,682. The solvency ratio was 60%.
- Gross Profit
- DKK 5,050,455
- Profit/Loss
- DKK 732,019
- Equity
- DKK 5,829,682
- Total Assets
- DKK 9,715,238
Official annual report
Keep an eye on IDEXX LABORATORIES DANMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of August 1, 2012, Ali Naqui is registered as director of IDEXX LABORATORIES DANMARK ApS.
On August 1, 2012, the company changed its name from IDEXX VET MED LAB ApS to IDEXX LABORATORIES DANMARK ApS.
As of April 26, 2012, Carl Jonas Larsson has stepped down as director of IDEXX LABORATORIES DANMARK ApS.
About IDEXX LABORATORIES DANMARK ApS
IDEXX LABORATORIES DANMARK ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Dyrlægeaktiviteter. The company was previously named IDEXX VET MED LAB ApS and VET.MED.LAB. ApS. The management consists of Geoffrey Scott Baur, Jeffery Donn Chadbourne and Lily Joann Lu. The company is owned by Vet Med Labor GmbH. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 10,595,778 and a net result of DKK 3,116,622 compared with DKK 3,271,491 the year before. Equity in the 2025 report amounted to DKK 23,178,172.